精品国产一区二区桃色

Member News

Jimah takes post; Bornfeldt gives lecture; Sullivan is interim chair

ASBMB Today Staff
Jan. 31, 2022

Jimah to join Princeton's molecular biology department 

John Jimah, a member of the inaugural class of ASBMB MOSAIC scholars, who was until recently a postdoctoral fellow at the National Institutes of Diabetes and Digestive and Kidney Diseases, has been appointed assistant professor in Princeton University's department of molecular biology starting this month.  

 

John Jimah

Jimah is a structural biologist, focusing on the mechanism of membrane remodeling in human cells and malaria parasites. Previously he discovered the mechanism of the malaria vaccine candidate CelTOS in forming pores in human and mosquito cells to allow parasite traversal and propagation. His recent postdoctoral studies on the architecture of human cell membranes include elucidating the mechanisms of dynamin/actin interaction during cell-cell fusion and dynamin-mediated membrane fission during endocytosis. The project he received MOSAIC funding for is titled "Structural basis of dynamin-mediated membrane fission, actin bundling and interaction with binding partners."

In addition to cryo-electron microscopy and tomography methods, Jimah uses a  technique called cryo-correlative light and electron microscopy — which combines multi-channel fluorescence imaging of a specific set of proteins with electron microscopy that gives more information about their structural context within cells — and plans to introduce it to Princeton's cryoEM facility. 

Jimah, who was raised in Ghana and attended Colgate University as an undergraduate, earned his Ph.D. in biology and biomedical sciences at Washington University in St. Louis. While a postdoc at NIDDK, he helped to start a seminar series called Trainees Recognizing Excellence and Diversity in Science, or TREaDS.

Bornfeldt gives ATVB Duff lecture

Karin Bornfeldt, a professor at the University of Washington and an associate editor of the Journal of Lipid Research, delivered the 2021 George Lyman Duff memorial lecture at the American Heart Association's annual meeting, which was held virtually in November.

Karin Bornfeldt

Bornfeldt, who has been at UW since she was hired as an assistant professor in 1998, spoke about her research into mechanisms for the increased risk of heart disease that many people with diabetes face. Her lab discovered that, even though diabetes primarily affects sugar metabolism, lipids are more important than glucose in accelerating atherosclerosis as a complication of diabetes. You can read more about her work in a recent interview with ASBMB Today.

The Duff Lecture, established in 1956, commemorates a founding member of the Society for the Study of Arteriosclerosis, which is now part of the American Heart Association. was a pathologist who studied arteriosclerosis, and a professor and later dean of the faculty at McGill University. The award is now administered by the Council on Arteriosclerosis, Thrombosis and Vascular Biology.

Sullivan named interim department chair at Indiana U med school

Bill Sullivan, Showalter professor at Indiana University School of Medicine, will serve as the interim chair of the pharmacology and toxicology department starting in June. He succeeds Bryan Yamamoto, who is retiring after holding the post for seven years, and will serve until a new chair is named.

Bill Sullivan

Sullivan's research focuses on the parasite Toxoplasma gondii, which he first became interested in as a graduate student at the University of Pennsylvania. After earning his Ph.D., he completed postdoctoral fellowships at Eli Lilly and then at Indiana University School of Medicine, where he became an assistant professor in 2003. 

T. gondii, an intracellular protozoan parasite that can famously be acquired from cat litter, can cause birth defects if contracted during pregnancy, sparks opportunistic infection in people whose immune systems are suppressed and increasingly appears to be linked to neurological disorders such as schizophrenia. Sullivan’s lab seeks tractable drug targets, focusing particularly on T. gondii enzymes that regulate gene expression: histone acetyltransferases that alter epigenetic status, eIF2 kinases that control translation initiation, and acetylases that operate outside of the nucleus.

Sullivan dedicates considerable energy to popular science communication. He is the author of the 2019 book “Pleased to Meet Me: Germs, Genes and the Curious Forces That Make Us Who We Are,” and is a prolific writer for popular science magazines, websites and other outlets — including ASBMB Today. He is also chair of ASBMB Today's editorial advisory board.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.